Talk:PALB2

Prophylactic mastectomy
The article states "Prophylactic mastectomy should be considered for women that had breast cancer and a PALB2 mutation." However, looking up the citations a very different image emerges. The first citation is the very decisive conclusion of a panel of experts, and the second part of an article with no explicit bottom line but an implicit admission. Let the reader judge whether the article is correct. (21) "Contralateral prophylactic mastectomy is rarely recommended for women with unilateral breast cancer." (22) "Contralateral prophylactic mastectomy may not improve overall survival". I'm not a specialist in the field so I'm avoiding editing the main article, but still felt like a note should be made. — Preceding unsigned comment added by 93.41.56.8 (talk) 23:43, 18 November 2022 (UTC)

Is this article about the gene or protein?
The lead says the gene and protein are both named PALB2. TimTempleton (talk) (cont)  22:35, 18 November 2020 (UTC)
 * Both, I think. Seems to be standard in articles about associated genes and proteins.Citing (talk) 00:00, 19 November 2020 (UTC)